Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correction (v204,p338)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, F. T.
Right arrow Articles by Sproat, I. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, F. T., Jr
Right arrow Articles by Sproat, I. A.

Radiology, Vol 203, 465-470, Copyright © 1997 by Radiological Society of North America

ARTICLES

CT depiction of experimental liver tumors: contrast enhancement with hepatocyte-selective iodinated triglyceride versus conventional techniques [published erratum appears in Radiology 1997 Aug;204(2):338]

FT Lee Jr, SG Chosy, SG Naidu, S Goldfarb, JP Weichert, DA Bakan, JE Kuhlman, RH Tambeaux and IA Sproat
Department of Radiology, University of Wisconsin Hospital and Clinics, Madison 53792-3252, USA.

PURPOSE: To compare findings at computed tomography (CT) enhanced with a hepatocyte-selective contrast agent (iodinated triglyceride) and/or iohexol and at CT during arterial portography (CTAP). MATERIALS AND METHODS: Rabbit livers were directly inoculated with VX2 carcinoma. Results were compared for five helical CT examinations: unenhanced CT, iohexol-enhanced CT (600 mg iodine per kilogram of body weight [mg I/kg]), CTAP (with iohexol [600 mg I/kg]), triglyceride-enhanced CT (126 mg I/kg), and dual-contrast-enhanced CT (triglyceride plus iohexol [425 mg I/kg]). Attenuation of normal liver and tumor were compared with analysis of variance techniques and blinded reader evaluations. RESULTS: Normal liver attenuation was greatest at CTAP (127.3 HU +/- 5.3 [mean +/- standard error of the mean]), followed by dual-contrast- enhanced CT (112.4 HU +/- 1.2), iohexol-enhanced CT (97.9 HU +/- 2.2), triglyceride-enhanced CT (82.3 HU +/- 1.1), and unenhanced CT (54.9 HU +/- 1.8). Liver-to-lesion attenuation difference at triglyceride- enhanced CT was significantly greater than at iohexol-enhanced CT (P < .05), and attenuation differences at dual-contrast-enhanced CT were comparable to those at CTAP. Tumors did not enhance at triglyceride- enhanced CT, which increased conspicuity. Sensitivity values for lesion detection at dual-contrast-enhanced CT were greater than those at iohexol-enhanced CT or at CTAP (P < .05). CONCLUSION: At CT enhanced with triglyceride (especially when combined with iohexol), sensitivity values and liver-to-lesion attenuation differences were greater with lower iodine doses than with iohexol or at CTAP.


This article has been cited by other articles:


Home page
 RadiologyHome page
J. P. Weichert, F. T. Lee Jr, S. G. Chosy, M. A. Longino, J. E. Kuhlman, D. M. Heisey, and G. E. Leverson
Combined Hepatocyte-selective and Blood-Pool Contrast Agents for the CT Detection of Experimental Liver Tumors in Rabbits
Radiology, September 1, 2000; 216(3): 865 - 871.
[Abstract] [Full Text]

Home page
 Am. J. Roentgenol.Home page
B. S. Kuszyk, D. A. Bluemke, M. A. Choti, K. M. Horton, C. A. Magee, and E. K. Fishman
Contrast-Enhanced CT of Small Hypovascular Hepatic Tumors: Effect of Lesion Enhancement on Conspicuity in Rabbits
Am. J. Roentgenol., February 1, 2000; 174(2): 471 - 0.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1997 by the Radiological Society of North America.